| Dr Rick G Lundgren, OD | |
|
180 Michigan Ave., Orofino, ID 83544-9066 | |
| (208) 476-4814 | |
| (208) 476-3921 |
| Full Name | Dr Rick G Lundgren |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 39 Years |
| Location | 180 Michigan Ave., Orofino, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649266040 | NPI | - | NPPES |
| 002600100 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | ODP-729 (Idaho) | Primary |
| Provider Name | Family Eye Care Of Orofino, P.a. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1629210331 PECOS PAC ID: 8325197544 Enrollment ID: O20090519000278 |
News Archive
What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.
At the Institut Curie, Inserm researchers and physicians have established the largest ever panel of human breast cancer xenografts in animal models.
Infertility is consistently listed as one of the most distressing long-term side effects of cancer treatment for adolescents and young adults. Yet the leading National Cancer Institute-designated comprehensive cancer centers - which should be leaders in fertility preservation - aren't doing an adequate job of helping patients protect their fertility, reports a new Northwestern Medicine- study.
Scientists at The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust have made a significant breakthrough in the fight against Membranous Nephropathy (MN) - a rare kidney disease which can lead to kidney failure.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rick G Lundgren, OD Po Box 147, Orofino, ID 83544-0147 Ph: (208) 476-4814 | Dr Rick G Lundgren, OD 180 Michigan Ave., Orofino, ID 83544-9066 Ph: (208) 476-4814 |
News Archive
What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.
At the Institut Curie, Inserm researchers and physicians have established the largest ever panel of human breast cancer xenografts in animal models.
Infertility is consistently listed as one of the most distressing long-term side effects of cancer treatment for adolescents and young adults. Yet the leading National Cancer Institute-designated comprehensive cancer centers - which should be leaders in fertility preservation - aren't doing an adequate job of helping patients protect their fertility, reports a new Northwestern Medicine- study.
Scientists at The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust have made a significant breakthrough in the fight against Membranous Nephropathy (MN) - a rare kidney disease which can lead to kidney failure.
› Verified 3 days ago
Eye Clinic Of Orofino Optometrist Medicare: Medicare Enrolled Practice Location: 906 Michigan Ave., Orofino, ID 83544 Phone: 208-476-3815 Fax: 208-476-3815 | |
Adam C Dayley, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 906 Michigan Avenue, Orofino, ID 83544 Phone: 208-476-3815 | |
Family Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 180 Michigan Ave., Orofino, ID 83544 Phone: 208-476-4814 Fax: 208-476-3921 |